BioCentury
ARTICLE | Clinical News

Androgel-DHT: UMED began Phase III testing

September 15, 1997 7:00 AM UTC

Unimed Pharmaceuticals Inc. (UMED), Buffalo Grove, Ill. Product: Androgel-DHT gel formulation of dihydrotestosterone Indication: Boost low testosterone in elderly men Status: UMED began Phase III tes...